CALCIUM ACETATE
Calcium acetate helps patients with end stage renal disease manage their phosphorus levels. It is used to lower high serum phosphorus concentrations that often occur when the kidneys are no longer functioning effectively. This medication acts as a phosphate binder to help maintain healthier mineral balances in the blood.
How CALCIUM ACETATE Works
This drug works by combining with phosphate found in food when taken during meals. This interaction creates an insoluble calcium phosphate complex that the body cannot absorb. The complex is then excreted through the feces, which effectively reduces the overall concentration of phosphorus in the blood.
Details
- Status
- Prescription
- First Approved
- 2008-01-30
- Routes
- ORAL
- Dosage Forms
- CAPSULE, TABLET
Companies
CALCIUM ACETATE Approval History
What CALCIUM ACETATE Treats
2 indicationsCALCIUM ACETATE is approved for 2 conditions since its original approval in 2008. These indications span multiple therapeutic areas including oncology, immunology, and more.
- End stage renal disease
- High serum phosphorus
CALCIUM ACETATE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Clinical Trial Registry
3 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04299633 | AKB-6548-CI-0037 | Ph 1 | completed | Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat |
| NCT01277497 | 2902 | Ph 4 | terminated | Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 |
| NCT01135615 | GATAFGF23Sevelamer | Ph 4 | completed | Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CALCIUM ACETATE FDA Label Details
Indications & Usage
CALCIUM ACETATE is indicated for the treatment of End stage renal disease; High serum phosphorus.
Looking for the branded version?
PHOSLYRA
Full clinical data, patents, trials, and competitive landscape for calcium acetate.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.